Top Tech Companies in Singapore (3,754)

Product Line Growth: Company updates point to a meaningful increase in product count in 2024, expanding the breadth of tradable products. Available evidence suggests this reflects operating-scale growth beyond hiring alone.

Market Expansion: The firm operates across Chicago, Boulder, New York, and Singapore, and signals expansion into new instruments and marketplaces domestically and globally. Physical office build-outs in Chicago further indicate an expanded footprint to accommodate growth.

Innovation-Driven Growth: Reported large increases in computing resources and major network upgrades in 2024 underscore ongoing investment in proprietary technology and infrastructure. Available evidence suggests these capacity gains are aimed at scaling trading capabilities.

Profitability: Bottom-line performance is strengthening, with consistent earnings beats, improved non-GAAP operating income, and durable free cash flow. Management is prioritizing margin expansion alongside operational efficiency.

Healthy Cash Flow: The business is generating solid free cash flow, with recent periods and guidance pointing to sustained cash generation. This supports stability even as revenue growth moderates.

Strong Market Position & Advantage: The company is repeatedly recognized as a leader in MDR, exposure management, and SIEM by major analyst programs. A large global customer base underscores established scale in its core markets.

Diversified Revenue Streams: Services and data-related lines are expanding at record levels, adding recurring income alongside core trading commissions. Information, post-trade, and technology services provide a broader and more resilient mix.

Product Line Growth: Newer trading protocols and products are scaling strongly, with portfolio and block trading reaching record activity. International products such as emerging markets and eurobonds are also contributing meaningful volume gains.

Strong Market Position & Advantage: The platform holds a leading position in electronic credit trading with broad institutional adoption and a differentiated all-to-all liquidity model. This entrenched network supports continued expansion across key categories.

Strong Market Position & Advantage: Greif is positioned as a top-tier global player in rigid industrial packaging (drums, IBCs/jerrycans) with a large footprint and an integrated offering that includes reconditioning and circular programs.

Cost & Operational Efficiency: Profitability improvements are attributed to aggressive cost optimization, with margin expansion and stated progress toward sizable run-rate savings even amid muted industrial demand.

Investor Backing & Capital Strength: Balance-sheet flexibility improved following major divestitures, with proceeds used to reduce debt and leverage and support capital returns and reinvestment capacity.

Resilient & Sustainable Growth: Firmwide AUM rose from $508 billion (December 31, 2024) to $538 billion (June 30, 2025), with communications also citing about $558 billion by September 30, 2025, alongside upward momentum through 2024–2025. The business has been growing particularly in private markets and credit, with activity across secondaries, co‑investments, and evergreen offerings.

Investor Backing & Capital Strength: Oversubscribed closes include about $4.0 billion for a GP‑led secondaries fund, $2.8 billion for a co‑investment fund, over $1.6 billion for Specialty Finance Fund III, and $7.3 billion (including leverage) for Private Debt V. These raises indicate strong investor demand and ample capital to deploy across private markets strategies.

Product Line Growth: Evergreen and private‑wealth access vehicles have been expanding, with the NB Private Markets Access Fund and the NB Global Private Equity Access Fund each surpassing $1 billion. The firm has broadened its distribution through semi‑liquid/private markets products while continuing to add vehicles across secondaries, co‑investments, and credit.

Strong Revenue Growth: Revenue run rate is repeatedly described as surging into the tens of billions, with estimates around $25–$40B and rapid acceleration from late 2025 into 2026, fueled by commercial demand for ChatGPT and APIs. This points to steep year-over-year scaling and a rising enterprise mix.

Investor Backing & Capital Strength: Multi‑billion‑dollar financings and tenders at an approximately $852B valuation, alongside marquee partnerships with hyperscalers and chip providers, underscore deep access to capital. These events are positioned to fund large‑scale compute, data centers, and talent for continued expansion.

Strong Market Position & Advantage: OpenAI is consistently portrayed as a primary market leader with massive user reach and broad enterprise adoption, including significant Fortune 500 penetration. Distribution via major platforms and integrations further reinforces its competitive stance even amid tight rivalry.

Strong Market Position & Advantage: Multiple third-party descriptions and industry recognitions portray Kroll as a leading independent provider in financial and risk advisory, with top placements in areas like fairness opinions and investigations/forensics. Scale signals such as a global workforce and long operating history reinforce a durable competitive position.

Market Expansion: Evidence points to active expansion through new practices (e.g., Economics and Decision Intelligence), geographic build-outs, and acquisitions across regions including APAC, Europe, and Latin America. Announcements of added services and locations indicate an expanding footprint.

Diversified Revenue Streams: A broad portfolio spanning valuation, investigations, due diligence, compliance, cyber/MDR/IR, restructuring, and agency/trustee services suggests multiple demand drivers. Recognition across several distinct service lines implies revenue is not dependent on a single offering.

Strong Market Position & Advantage: Evidence indicates S&P Global holds leading positions in credit ratings, flagship equity indices, and commodity benchmarks, reinforced by the IHS Markit merger. Feedback suggests its indices and PMI suite are deeply embedded in market infrastructure and widely used by investors and policymakers.

Strong Revenue Growth: Reported results indicate revenue, earnings, and margins increased in full-year 2025 and in Q1 2026, with management guiding to continued growth in 2026. Filings describe broad-based divisional gains and margin expansion alongside active capital returns.

Diversified Revenue Streams: Disclosures describe multiple businesses—Ratings, Indices, Market Intelligence, Energy, and Mobility—each contributing to recent growth. Commentary highlights this mix as a buffer against cyclicality and a source of resilience across market conditions.

Strong Market Position & Advantage: Edwards is broadly characterized as the TAVR category leader anchored by the SAPIEN portfolio, and its first-to-approval EVOQUE tricuspid replacement reinforces leadership across structural heart. Industry trackers and company updates point to durable share and breadth across aortic, mitral, and tricuspid therapies.

Strong Revenue Growth: Recent results show double-digit top-line expansion and successive raises to the 2026 sales outlook, driven by steady TAVR demand and rapid TMTT growth. Management commentary emphasizes continued momentum with a consistent long-term growth ambition.

Innovation-Driven Growth: First-to-approval EVOQUE in tricuspid replacement, rapid uptake of PASCAL in mitral repair, and extensive long-term SAPIEN evidence position the portfolio for further adoption. Regulatory and policy catalysts, including a pending CMS TAVR coverage reconsideration and accumulating durability data, may expand access.